Search bioRxiv⌕ Search

Biology subjects

Köttgen, A.

Publications and source records attributed to Köttgen, A..

4 recordsLinked to original sources

Molecular determinants of selective and high-affinity binding of the scaffold protein PDZK1 to the transporter URAT1

The renal solute carrier URAT1 (SLC22A12) is essential for urate homeostasis, with loss-of-function linked to renal hypouricemia, nephrolithiasis and lower gout risk. URAT1 function depends on binding the multi-PDZ domain scaffold protein PDZK1 (NHERF3), with a similar role suggested for the related NHERF1. The molecular basis of these interactions remains poorly understood. Using fluorescence anisotropy, we show that full-length human PDZK1 binds the C-terminal peptide of URAT1 with high affinity (KD 170 nM), unlike NHERF1 (KD >70 {micro}M). The PDZ1 domain of PDZK1 alone is sufficient for high-affinity binding (KD 160 nM), while PDZ4 provides a secondary site (KD 1.35 {micro}M), with both interactions characterized by rapid kinetics. Gel filtration shows that PDZK1 can bind two URAT1 peptides. X-ray structures of individual PDZ domains from PDZK1 and NHERF1 complexed with the URAT1 peptide reveal the molecular determinants for PDZK1s higher affinity and selectivity. Murine Pdzk1 and Nherf1 bind Urat1 with high affinity indicating species-specific interactions. These data provide insights into URAT1 regulation by PDZ scaffold proteins with relevance for understanding urate homeostasis regulation and related disorders.

biochemistry↗

Designing Single-Cell RNA-Sequencing Experiments for Learning Latent Representations

To investigate the complexity arising from single-cell RNA-sequencing (scRNA-seq) data, researchers increasingly resort to deep generative models, specifically variational autoencoders (VAEs), which are trained by variational inference techniques. Similar to other dimension reduction approaches, this allows encoding the inherent biological signals of gene expression data, such as pathways or gene programs, into lower-dimensional latent representations. However, the number of cells necessary to adequately uncover such latent representations is often unknown. Therefore, we propose a single-cell variational inference approach for designing experiments (scVIDE) to determine statistical power for detecting cell group structure in a lower-dimensional representation. The approach is based on a test statistic that quantifies the contribution of every single cell to the latent representation. Using a smaller scRNA-seq data set as a starting point, we generate synthetic data sets of various sizes from a fitted VAE. Employing a permutation technique for obtaining a null distribution of the test statistic, we subsequently determine the statistical power for various numbers of cells, thus guiding experimental design. We illustrate with several data sets from various sequencing protocols how researchers can use scVIDE to determine the statistical power for cell group detection within their own scRNA-seq studies. We also consider the setting of transcriptomics studies with large numbers of cells, where scVIDE can be used to determine the statistical power for sub-clustering. For this purpose, we use data from the human KPMP Kidney Cell Atlas and evaluate the power for sub-clustering of the epithelial cells contained therein. To make our approach readily accessible, we provide a comprehensive Jupyter notebook at https://github.com/MTreppner/scVIDE.jl that researchers can use to design their own experiments based on scVIDE.

bioinformatics↗

Large Bi-Ethnic Study of Plasma Proteome Leads to Comprehensive Mapping of cis-pQTL and Models for Proteome-wide Association Studies

Improved understanding of genetic regulation of proteome can facilitate the identification of causal mechanisms for complex traits. We analyzed data on 4,657 plasma proteins from 7,213 European American (EA) and 1,871 African American (AA) individuals from the ARIC study, and further replicated findings on 467 AA individuals from the AASK study. Here we identified 2,004 proteins in EA and 1,618 in AA, with majority overlapping, which showed associations with common variants in cis-regions. Availability of AA samples led to smaller credible sets and significant number of population-specific cis-pQTLs. Elastic-net produced powerful models for protein prediction in both populations. An application of proteome-wide association studies (PWAS) to serum urate and gout, implicated several proteins, including IL1RN, revealing the promise of the drug anakinra to treat acute gout flares. Our study demonstrates the value of large and diverse ancestry study for genetic mechanisms of molecular phenotypes and their relationship with complex traits.

genetics↗

Investigation of an LPA KIV-2 nonsense mutation in 11,000 individuals: the importance of linkage disequilibrium structure in LPA genetics.

ObjectiveElevated Lp(a) plasma concentrations are determined mainly genetically by the LPA gene locus, but up to 70% of the coding sequence is located in the so-called "kringle IV type 2" (KIV-2) copy number variation. This region is not resolved by common genotyping technologies and large epidemiological studies on this region are therefore missing. The Arg21Ter variant (R21X, variant frequency {approx}2%) is a functional variant in this region, but it has never been analyzed in large cohorts and is it unknown whether it is captured by genome-wide association studies. Approach and ResultsWe developed a highly sensitive allele-specific qPCR assay and genotyped R21X in 10,910 individuals from three populations (GCKD, KORA F3, KORA F4). R21X carriers showed significantly lower mean Lp(a) concentrations (-11.7 mg/dL [-15.5;-7.82], p=3.39e-32). Of particular note, virtually all R21X carriers also carried the splice mutation rs41272114 (D=0.957, R2=0.275), as confirmed by pulsed-field gel electrophoresis and long-range haplotyping. This proposes that the R21X mutation arose on the background of the rs41272114 splice variant. ConclusionsWe performed the largest epidemiological study on an LPA KIV-2 variant so far. Interestingly, R21X is located on the same haplotype as the splice mutation rs41272114, creating "double-null" LPA alleles that are inactivated by two independent mutations. The effect of the R21X nonsense mutation can thus not be discerned from the effect of rs41272114 splice site mutation. This emphasizes the importance of assessing the complex LD structure within LPA even for functional variants.

genetics↗